ARIYA

Welcome to the Brand page for “ARIYA”, which is offered here for Immunotherapeutic agents, antibodies, vaccines, and pharmaceutical preparations thereof for the treatment of cancer and neurodegenerative, neurodevelopmental and cognitive disorders; therapeutic agents for transport and delivery of small molecules and biologics to the lymphatic system; exosome-based pharmaceutical preparations to facilitate the oral administration and delivery of therapeutic agents; pharmaceutical preparations for the modulation of lymphatic function in the brain for the treatment, prevention, and delayed onset of central nervous system disorders, alzheimer's disease, huntington's disease, age-associated cognitive decline and diseases associated with neurodegenerative, neurodevelopmental and cognitive disorders; therapeutic agents for the treatment of fibrotic diseases, interstitial lung disease, pulmonary fibrosis, lymphedema, sclerosis, and scleroderma;.

Its status is currently believed to be active. Its class is unavailable. “ARIYA” is believed to be currently owned by “PureTech Health LLC”.